Related Experiment Video
Updated: Aug 18, 2025

11:29
Cost-effective Method for Microbial Source Tracking Using Specific Human and Animal Viruses
Published on: December 3, 2011
12.3K
PHYLOGENETIC ANALYSIS OF BOVINE PESTIVIRUSES DETECTED IN SIBERIA
A G Glotov1, S V Koteneva1, T I Glotova1
1Siberian Federal Scientific Centre of Agro-biotechnologies, Institute of Experimental Veterinary Science of Siberia and the Far East.
Voprosy Virusologii
|December 10, 2022
Summary
Bovine pestiviruses, including BVDV1 subtypes and BVDV2, circulate in Siberian cattle, with BVDV1b predominant. Atypical BVDV3 was found in fetal bovine serum, highlighting regional viral diversity and control strategy needs.
Area of Science:
- Veterinary Virology
- Molecular Epidemiology
- Animal Health
Background:
- Bovine pestiviruses (BPV) are significant pathogens affecting cattle health and productivity.
- Understanding the genetic diversity and circulation of BPV is crucial for effective disease control.
Purpose of the Study:
- To characterize the genetic diversity and geographical distribution of bovine pestiviruses in Siberia.
- To identify BPV subtypes in cattle, cell cultures, and fetal bovine serum (FBS).
Main Methods:
- Phylogenetic analysis based on the 5' untranslated region (5'-UTR) of the viral genome.
- Detection of pestiviruses in cattle, persistently infected (PI) animals, cell cultures, and FBS samples.
Main Results:
- Five BVDV1 subtypes (a, b, d, f, r) and BVDV2 were identified in Siberian cattle, with BVDV1b being the most prevalent (48%).
- Geographical variations in virus distribution were observed, with different subtypes associated with specific clinical signs or host types.
- Atypical BVDV3 was detected in FBS from two manufacturers, but not found circulating in local animal populations.
Conclusions:
- The study reveals a complex landscape of bovine pestivirus circulation in Siberia, with implications for disease management.
- Molecular epizootology data is essential for developing targeted control strategies and optimizing vaccine use in the region.

